{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:11:35Z","timestamp":1789085495996,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2024ZD0537908"],"award-info":[{"award-number":["2024ZD0537908"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20813"],"award-info":[{"award-number":["U24A20813"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273919"],"award-info":[{"award-number":["82273919"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270396"],"award-info":[{"award-number":["82270396"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570453"],"award-info":[{"award-number":["82570453"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009993","name":"Excellent Youth Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["JJ2023YX0509"],"award-info":[{"award-number":["JJ2023YX0509"]}],"id":[{"id":"10.13039\/501100009993","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jare.2025.11.044","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:44:27Z","timestamp":1763750667000},"page":"709-727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Identification and evaluation of a lipid-lowering small compound as a PCSK9 inhibitor"],"prefix":"10.1016","volume":"86","author":[{"given":"Run","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xutong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijia","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2025.11.044_b0005","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s12967-022-03623-0","article-title":"Integrated lipidomics and network pharmacology analysis to reveal the mechanisms of berberine in the treatment of hyperlipidemia","volume":"20","author":"Chen","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.jare.2025.11.044_b0010","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cca.2021.03.024","article-title":"MicroRNA in cardio-metabolic disorders","volume":"518","author":"Su","year":"2021","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jare.2025.11.044_b0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.eng.2023.03.004","article-title":"Bioactive components of chinese herbal medicines in the treatment of glucose and lipid metabolism disorders: evidence and potential mechanisms","volume":"29","author":"Zhang","year":"2023","journal-title":"Engineering"},{"key":"10.1016\/j.jare.2025.11.044_b0020","first-page":"830","article-title":"SBC (Sanhuang Xiexin Tang combined with Baihu Tang plus Cangzhu) alleviates NAFLD by enhancing mitochondrial biogenesis and ameliorating inflammation in obese patients and mice","volume":"21","author":"Ren","year":"2023","journal-title":"Chin J Nat Med"},{"key":"10.1016\/j.jare.2025.11.044_b0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.atherosclerosis.2017.04.010","article-title":"Identifying low density lipoprotein cholesterol associated variants in the Annexin A2 (ANXA2) gene","volume":"261","author":"Fairoozy","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jare.2025.11.044_b0030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/CIRCULATIONAHA.122.063372","article-title":"Orally bioavailable macrocyclic peptide that inhibits binding of PCSK9 to the low density lipoprotein receptor","volume":"148","author":"Johns","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jare.2025.11.044_b0035","first-page":"897","article-title":"The surgical treatment of male pattern baldness","volume":"24","author":"Adamson","year":"1969","journal-title":"J Am Med Womens Assoc"},{"key":"10.1016\/j.jare.2025.11.044_b0040","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/MED.0000000000000764","article-title":"Statin therapy is not warranted for a person with high LDL-cholesterol on a low-carbohydrate diet","volume":"29","author":"Diamond","year":"2022","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jare.2025.11.044_b0045","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.2174\/1381612824666181010144823","article-title":"Pharmacology of PCSK9 inhibitors: current status and future perspectives","volume":"24","author":"Tsouka","year":"2018","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jare.2025.11.044_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108480","article-title":"Targeting PCSK9 to tackle cardiovascular disease","volume":"249","author":"Hummelgaard","year":"2023","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jare.2025.11.044_b0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.chembiol.2021.08.012","article-title":"Identification of a PCSK9-LDLR disruptor peptide with invivo function","volume":"29","author":"Brousseau","year":"2022","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.jare.2025.11.044_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115880","article-title":"PCSK9 biology and its role in atherothrombosis","volume":"22","author":"Barale","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.11.044_b0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000028766","article-title":"Pediatric atlantoaxial instability: management with screw fixation","volume":"30","author":"Wang","year":"1999","journal-title":"Pediatr Neurosurg"},{"key":"10.1016\/j.jare.2025.11.044_b0070","doi-asserted-by":"crossref","first-page":"9447","DOI":"10.1021\/acs.chemrev.3c00054","article-title":"Recent advances in the total synthesis of the tetrahydroisoquinoline alkaloids (2002-2020)","volume":"123","author":"Kim","year":"2023","journal-title":"Chem Rev"},{"key":"10.1016\/j.jare.2025.11.044_b0075","unstructured":"Y. Zhang, B. Yang, X. Liu, W. Han, and L. Zhao, Inventors."},{"key":"10.1016\/j.jare.2025.11.044_b0080","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.2174\/1568026620666200908165913","article-title":"Berberine: a promising natural isoquinoline alkaloid for the development of hypolipidemic drugs","volume":"20","author":"Li","year":"2020","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.jare.2025.11.044_b0085","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fphar.2016.00362","article-title":"Rhizoma coptidis: a potential cardiovascular protective agent","volume":"7","author":"Tan","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jare.2025.11.044_b0090","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/09637486.2024.2342301","article-title":"Dietary supplements: clinical cholesterol-lowering efficacy and potential mechanisms of action","volume":"75","author":"Ge","year":"2024","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.jare.2025.11.044_b0095","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/1747493018778713","article-title":"Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke","volume":"13","author":"Sacks","year":"2018","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jare.2025.11.044_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115839","article-title":"Targeted protein degradation in drug development: recent advances and future challenges","volume":"261","author":"Song","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jare.2025.11.044_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/cells11192972","article-title":"PCSK9 inhibition: from current advances to evolving future","volume":"11","author":"Liu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jare.2025.11.044_b0110","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1074\/jbc.M114.597229","article-title":"Inhibition of PCSK9 transcription by berberine involves down-regulation of hepatic HNF1\u03b1 protein expression through the ubiquitin-proteasome degradation pathway","volume":"290","author":"Dong","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2025.11.044_b0115","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm1135","article-title":"Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins","volume":"10","author":"Kong","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.jare.2025.11.044_b0120","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1194\/jlr.M003566","article-title":"Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters","volume":"51","author":"Dong","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jare.2025.11.044_b0125","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2147\/IJGM.S460305","article-title":"Statin-associated liver dysfunction and muscle injury: epidemiology, mechanisms, and management strategies","volume":"17","author":"Ma","year":"2024","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.jare.2025.11.044_b0130","doi-asserted-by":"crossref","first-page":"43054","DOI":"10.1074\/jbc.M111.273474","article-title":"Novel domain interaction regulates secretion of proprotein convertase subtilisin\/kexin type 9 (PCSK9) protein","volume":"286","author":"Du","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2025.11.044_b0135","doi-asserted-by":"crossref","first-page":"12882","DOI":"10.1074\/jbc.M110.113035","article-title":"A proprotein convertase subtilisin-like\/kexin type 9 (PCSK9) C-terminal domain antibody antigen-binding fragment inhibits PCSK9 internalization and restores low density lipoprotein uptake","volume":"285","author":"Ni","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2025.11.044_b0140","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1038\/s41401-024-01305-9","article-title":"A novel small-molecule PCSK9 inhibitor E28362 ameliorates hyperlipidemia and atherosclerosis","volume":"45","author":"Wang","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jare.2025.11.044_b0145","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s00335-024-10055-2","article-title":"E3 ubiquitin ligase MARCH1 reduces inflammation and pyroptosis in cerebral ischemia-reperfusion injury via PCSK9 downregulation","volume":"35","author":"Guo","year":"2024","journal-title":"Mamm Genome"},{"key":"10.1016\/j.jare.2025.11.044_b0150","doi-asserted-by":"crossref","first-page":"12086","DOI":"10.3390\/molecules171012086","article-title":"c-IAP1 binds and processes PCSK9 protein: linking the c-IAP1 in a TNF-\u03b1 pathway to PCSK9-mediated LDLR degradation pathway","volume":"17","author":"Xu","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.jare.2025.11.044_b0155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-022-00966-4","article-title":"Targeted protein degradation: mechanisms, strategies and application","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jare.2025.11.044_b0160","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1021\/cb400889a","article-title":"Potent and selective small-molecule inhibitors of cIAP1\/2 proteins reveal that the binding of Smac mimetics to XIAP BIR3 is not required for their effective induction of cell death in tumor cells","volume":"9","author":"Sun","year":"2014","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.jare.2025.11.044_b0165","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.114.301621","article-title":"PCSK9: a key modulator of cardiovascular health","volume":"114","author":"Seidah","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jare.2025.11.044_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27020434","article-title":"PCSK9 as a target for development of a new generation of hypolipidemic drugs","volume":"27","author":"Kuzmich","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jare.2025.11.044_b0175","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejmech.2018.11.011","article-title":"Small molecules as inhibitors of PCSK9: current status and future challenges","volume":"162","author":"Xu","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jare.2025.11.044_b0180","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S2213-8587(23)00325-X","article-title":"PCSK9 inhibition with orally administered NNC0385-0434 in hypercholesterolaemia: a randomised, double-blind, placebo-controlled and active-controlled phase 2 trial","volume":"12","author":"Koren","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jare.2025.11.044_b0185","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.jacc.2025.03.499","article-title":"An Oral PCSK9 inhibitor for treatment of hypercholesterolemia: the PURSUIT randomized trial","volume":"85","author":"Koren","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jare.2025.11.044_b0190","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jacc.2023.02.018","article-title":"Phase 2b randomized trial of the oral PCSK9 inhibitor MK-0616","volume":"81","author":"Ballantyne","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jare.2025.11.044_b0195","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/cpch.27","article-title":"Overview of methods and strategies for conducting virtual small molecule screening","volume":"9","author":"Fradera","year":"2017","journal-title":"Curr Protoc Chem Biol"},{"key":"10.1016\/j.jare.2025.11.044_b0200","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2174\/1570163812666150702121809","article-title":"Discovery approaches for novel dyslipidemia drugs","volume":"12","author":"Maqbool","year":"2015","journal-title":"Curr Drug Discov Technol"},{"key":"10.1016\/j.jare.2025.11.044_b0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22063144","article-title":"Pleiotropic effects of PCSK-9 inhibitors","volume":"22","author":"Basiak","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.11.044_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155291","article-title":"Pancreatic PCSK9 controls the organization of the \u03b2-cell secretory pathway via LDLR-cholesterol axis","volume":"136","author":"Marku","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.jare.2025.11.044_b0215","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12933-018-0689-9","article-title":"Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db\/db mice through a HNF-1a dependent mechanism","volume":"17","author":"Yang","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jare.2025.11.044_b0220","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/eurheartj\/ehx260","article-title":"The AT04A vaccine against proprotein convertase subtilisin\/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice","volume":"38","author":"Landlinger","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jare.2025.11.044_b0225","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1021\/acs.jcim.1c00521","article-title":"Discovery of novel small molecule inhibitors disrupting the PCSK9-LDLR interaction","volume":"61","author":"Sun","year":"2021","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.jare.2025.11.044_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129394","article-title":"Small molecule inhibitors of PCSK9. SAR investigations of head and amine groups","volume":"92","author":"Aspnes","year":"2023","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jare.2025.11.044_b0235","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2015.09.032","article-title":"Berberine, a plant alkaloid with lipid- and glucose-lowering properties: from invitro evidence to clinical studies","volume":"243","author":"Pirillo","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jare.2025.11.044_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102650","article-title":"A small-molecule inhibitor of PCSK9 transcription ameliorates atherosclerosis through the modulation of FoxO1\/3 and HNF1\u03b1","volume":"52","author":"Wang","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jare.2025.11.044_b0245","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1039\/C8MD00297E","article-title":"Novel tricyclic glycal-based TRIB1 inducers that reprogram LDL metabolism in hepatic cells","volume":"9","author":"Nagiec","year":"2018","journal-title":"Medchemcomm"},{"key":"10.1016\/j.jare.2025.11.044_b0250","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/jcb.27102","article-title":"Berberrubine and its analog, hydroxypropyl-berberrubine, regulate LDLR and PCSK9 expression via the ERK signal pathway to exert cholesterol-lowering effects in human hepatoma HepG2 cells","volume":"120","author":"Cao","year":"2019","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jare.2025.11.044_b0255","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.cmet.2022.03.006","article-title":"Identification and evaluation of a lipid-lowering small compound in preclinical models and in a phase I trial","volume":"34","author":"Wang","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.jare.2025.11.044_b0260","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1161\/CIRCULATIONAHA.123.062788","article-title":"Immune regulation of the liver through the PCSK9\/CD36 pathway during heart transplant rejection","volume":"148","author":"Zhang","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jare.2025.11.044_b0265","doi-asserted-by":"crossref","first-page":"17167","DOI":"10.1038\/s41598-019-53603-6","article-title":"PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease","volume":"9","author":"Lee","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2025.11.044_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.149815","article-title":"Sesamin alleviates lipid accumulation induced by oleic acid via PINK1\/Parkin-mediated mitophagy in HepG2 cells","volume":"708","author":"Dong","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jare.2025.11.044_b0275","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12944-023-01983-0","article-title":"Genetic insights into the association of statin and newer nonstatin drug target genes with human longevity: a Mendelian randomization analysis","volume":"22","author":"Chen","year":"2023","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jare.2025.11.044_b0280","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301748R","article-title":"PCSK9 dysregulates cholesterol homeostasis and triglyceride metabolism in olanzapine-induced hepatic steatosis via both receptor-dependent and receptor-independent pathways","volume":"38","author":"Huang","year":"2024","journal-title":"FASEB J"},{"key":"10.1016\/j.jare.2025.11.044_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155111","article-title":"Xie Zhuo Tiao Zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy","volume":"121","author":"Qiu","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jare.2025.11.044_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155505","article-title":"A promising therapy for fatty liver disease: PCSK9 inhibitors","volume":"128","author":"Han","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jare.2025.11.044_b0295","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111687","article-title":"Statin-associated myopathy: emphasis on mechanisms and targeted therapy","volume":"22","author":"Vinci","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.11.044_b0300","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112467","article-title":"Inclisiran-silencing the cholesterol, speaking up the prognosis","volume":"10","author":"Rogula","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jare.2025.11.044_b0305","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00003088-199732050-00005","article-title":"Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences","volume":"32","author":"Lennern\u00e4s","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jare.2025.11.044_b0310","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1039\/C7FO00562H","article-title":"Welsh onion extract inhibits PCSK9 expression contributing to the maintenance of the LDLR level under lipid depletion conditions of HepG2 cells","volume":"8","author":"Choi","year":"2017","journal-title":"Food Funct"},{"key":"10.1016\/j.jare.2025.11.044_b0315","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.chembiol.2019.10.002","article-title":"From screening to targeted degradation: strategies for the discovery and optimization of small molecule ligands for PCSK9","volume":"27","author":"Petrilli","year":"2020","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.jare.2025.11.044_b0320","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1021\/acscentsci.5c00023","article-title":"Unraveling small molecule-mediated sirtuin 3 activation at a distinct binding site for cardioprotective therapies","volume":"11","author":"Zhang","year":"2025","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.jare.2025.11.044_b0325","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1038\/s41401-024-01307-7","article-title":"THBru attenuates diabetic cardiomyopathy by inhibiting RAGE-dependent inflammation","volume":"45","author":"Xu","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jare.2025.11.044_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116381","article-title":"Tetrahydroberberrubine exhibits preventive effect on obesity by activating PGC1\u03b1-mediated thermogenesis in white and brown adipose tissue","volume":"226","author":"Tang","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jare.2025.11.044_b0335","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41401-022-00956-w","article-title":"Tetrahydroberberrubine retards heart aging in mice by promoting PHB2-mediated mitophagy","volume":"44","author":"Wang","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jare.2025.11.044_b0340","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tem.2024.07.017","article-title":"The direct targets of metformin in diabetes and beyond","volume":"36","author":"Yao","year":"2025","journal-title":"Trends Endocrinol Metab"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225009403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225009403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:53:29Z","timestamp":1789084409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123225009403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":68,"alternative-id":["S2090123225009403"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2025.11.044","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and evaluation of a lipid-lowering small compound as a PCSK9 inhibitor","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2025.11.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}